Cramer Gives His Opinion On Service Corporation, Vertex And More

On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't happy with the way Inseego Corp INSG acts. He is beginning to believe it deserves to be trading 45% lower.

Biohaven Pharmaceutical Holding Co Ltd BHVN is instrumental, said Cramer. He likes its drug Nurtec.

Cramer is not a buyer of Service Corporation International SCI. He said there are ways to make COVID-19 less life-threatening than the last year.

Cramer is astonished at how much Vertex Pharmaceuticals VRTX has fallen given its cystic fibrosis franchise. He wouldn't sell it at its current price.

Posted In: CNBCJim Cramermad money Lightning RoundSmall CapMedia